Per Lindell
Vorstandsvorsitzender bei Panther Pharmaceuticals, Inc.
Ursprung des Netzwerks ersten Grades von Per Lindell
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Panther Pharmaceuticals, Inc.
Panther Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Panther Pharmaceuticals, Inc. operates as a biotechnology company. The company is headquartered in Cambridge, MA.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Per Lindell
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Founder | |
Bespoke, Inc.
Bespoke, Inc. Packaged SoftwareTechnology Services Bespoke, Inc. sells eyewear and provides assistance to retailers and eyewear brands to improve and expand their reach in the industry. The private company is based in San Francisco, CA. The company offers a virtual try-on feature and precise frame and lens measurements through their scan technology. The company aims to help both in-store and online businesses improve their customer experience and reduce return rates. The company was founded by Eric Varady, who has been the CEO since incorporation. | Packaged Software | Director/Board Member | |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Biotechnology | Chief Operating Officer |
Statistik
International
Vereinigte Staaten | 4 |
Sektoral
Commercial Services | 2 |
Technology Services | 2 |
Health Technology | 2 |
Operativ
Director/Board Member | 4 |
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Michael Tolentino | 4 |
- Börse
- Insiders
- Per Lindell
- Unternehmensverbindungen